Evaluating CMR

Imaging Techniques

Computed Tomography (CT)

References

Page: Go to Previous Page 9 of 9 Go to Next Page
  1. Heymsfield SB, Lohman TG, Wang Z, et al. Human Body Composition. 2005.
  2. Bray GA, Bouchard C and James WPT. Handbook of Obesity. 1998.
  3. Abate N, Burns D, Peshock RM, et al. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 1994; 35: 1490-6.
  4. Mourier A, Gautier JF, De Kerviler E, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM. Effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385-91.
  5. Kvist H, Sjostrom L and Tylen U. Adipose tissue volume determinations in women by computed tomography: technical considerations. Int J Obes 1986; 10: 53-67.
  6. Ross R, Rissanen J, Pedwell H, et al. Influence of diet and exercise on skeletal muscle and visceral adipose tissue in men. J Appl Physiol 1996; 81: 2445-55.
  7. Ross R. Magnetic resonance imaging provides new insights into the characterization of adipose and lean tissue distribution. Can J Physiol Pharmacol 1996; 74: 778-85.
  8. Shen W, Wang Z, Tang H, et al. Volume estimates by imaging methods: model comparisons with visible women as the reference. Obes Res 2003; 11: 217-25.
  9. Snyder WS, Cooke MJ, Manssett ES, et al. Report of the Task Group on Reference Man. 1975.
  10. Gallagher D, Belmonte D, Deurenberg P, et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol 1998; 275: E249-58.
  11. Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci 2001; 56: B209-17.
  12. Newman AB, Haggerty CL, Goodpaster B, et al. Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2003; 51: 323-30.
  13. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60: 324-33.
  14. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115-22.
  15. Lee SJ, Janssen I, Heymsfield SB, et al. Relation between whole-body and regional measures of human skeletal muscle. Am J Clin Nutr 2004; 80: 1215-21.
  16. Seidell JC, Bakker CJ and van der Kooy K. Imaging techniques for measuring adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr 1990; 51: 953-7.
  17. Ohsuzu F, Kosuda S, Takayama E, et al. Imaging techniques for measuring adipose-tissue distribution in the abdomen: a comparison between computed tomography and 1.5-tesla magnetic resonance spin-echo imaging. Radiat Med 1998; 16: 99-107.
  18. Rennie K, McCarthy N, Yazdgerdi S, et al. Association of the metabolic syndrome with both vigorous and moderate physical activity. Int. J. Epidemiol. 2003; 32: 600-6.
  19. Ekelund U, Griffin SJ, Wareham NJ, et al. Physical Activity and Metabolic Risk in Individuals With a Family History of Type 2 Diabetes. Diabetes Care 2007; 30: 337-42.
  20. Carroll S, Cooke CB, Butterly, et al. Metabolic clustering, physical activity and fitness in nonsmoking, middle-aged men. Med Sci Sports Exerc 2000; 32: 2079-86.
  21. Lakka TA, Laaksonen DE, Lakka HM, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 2003; 35: 1279-86.
  22. Thune I, Njolstad I, Lochen M-L, et al. Physical Activity Improves the Metabolic Risk Profiles in Men and Women: The Tromso Study. Arch Intern Med 1998; 158: 1633-40.
  23. Lemieux I, Pascot A, Lamarche B, et al. Is the gender difference in LDL size explained by the metabolic complications of visceral obesity? Eur J Clin Invest 2002; 32: 909-17.
  24. Kanaley JA, Sames C, Swisher L, et al. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status. Metabolism 2001; 50: 976-82.
  25. Lemieux S, Prud'homme D, Nadeau A, et al. Seven-year changes in body fat and visceral adipose tissue in women. Association with indexes of plasma glucose-insulin homeostasis. Diabetes Care 1996; 19: 983-91.
  26. Brochu M, Starling RD, Tchernof A, et al. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 2000; 85: 2378-84.
  27. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med 2004; 140: 992-1000.
  28. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 1999; 22: 1808-12.
  29. Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care 2000; 23: 465-71.
  30. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-83.
  31. Ross R, Aru J, Freeman J, et al. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002; 282: E657-63.
  32. Pouliot MC, Després JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992; 41: 826-34.
  33. Ross R, Freeman J, Hudson R, et al. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 2002; 87: 5044-51.
  34. Kuk JL, Katzmarzyk PT, Nichaman MZ, et al. Visceral Fat Is an Independent Predictor of All-cause Mortality in Men. Obes Res 2006; 14: 336-41.
  35. Kuk JL, Nichaman MZ, Church TS, et al. Liver fat is not a marker of metabolic risk in lean premenopausal women. Metabolism 2004; 53: 1066-71.
  36. Banerji MA, Buckley MC, Chaiken RL, et al. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995; 19: 846-50.
  37. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol 1997; 27: 108-13.
  38. Goto T, Onuma T, Takebe K, et al. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-5.
  39. Goodpaster BH, Kelley DE, Thaete FL, et al. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000; 89: 104-10.
  40. Piekarski J, Goldberg HI, Royal SA, et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980; 137: 727-9.
  41. Davidson LE, Kuk JL, Church TS, et al. Protocol for Measurement of Liver Fat by Computed Tomography. J Appl Physiol 2005.
  42. Nguyen-Duy TB, Nichaman MZ, Church TS, et al. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 2003; 284: E1065-71.
  43. Joy D, Thava VR and Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539-43.
Page: Go to Previous Page 9 of 9 Go to Next Page
Print this document